Bio-cat, Inc.

Moore, Kenneth Gregory

Edward Schuler

Christopher Schuler

Christopher S Penet

Kelly Gregory

Gregory S Moore

K Gregory Moore

Kenneth Gregory Moore

The invention relates to methods and compositions for reducing serum levels of triacylglycerides in human subjects. In particular, the invention relates to the oral administration of an effective amount of a fungal lipase formulation, to a human subject having borderline-high or high serum levels of triacylglycerides, for a time period sufficient to reduce serum triacylglyceride levels.

Methods and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase

Method and compositions to reduce serum levels of triacylglycerides in human beings using a fungal lipase

The invention provides compositions and methods for treating pancreatic enzyme insufficiency, such as the pancreatic enzyme insufficiency associated with cystic fibrosis. The invention also provides compositions comprising lipase from, alone or in combination with amylase or amyloglucosidase, protease and/or lactase. Furthermore, the invention discloses methods for treating pancreatic enzyme insufficiency comprising administering compositions to patients in need thereof.

Composition with a fungal (yeast) lipase and method for treating lipid malabsorption in cystic fibrosis as well as people suffering from pancreatic lipase insufficiency

Growing community of inventors

Keswick, VA, United States of America

Edward Schuler